Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03526107 · ClinicalTrials.gov registry record · NA
Food Matrix Effect on Flavanol Absorption, Metabolism and Excretion: Methylxanthines
A NA study of Healthy, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT03526107: Completed NA study of Healthy, sponsored by University of California, Davis.
NCT03526107 is a NA study of Healthy that has completed, run by University of California, Davis. The registered enrollment target is 10 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03526107, a NA study of Healthy, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
Dietary intervention study in healthy young adult males to evaluate concentration of flavanol metabolites in plasma and urine after single acute intakes of methylxanthines.
Primary Outcome
Plasma concentration of flavanol metabolites
Conditions Studied
Interventions
- OTHER CF Control
- OTHER CF-Theobromine
- OTHER CF-Caffeine
Study Locations (2)
California
- Ragle Human Nutrition Research Center, Department of Nutrition at UC Davis - Davis
- UC Davis - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-02-16 |
| Est. Completion | 2017-05-31 |
| Phase | NA |
What the finished NCT03526107 record still lists
NCT03526107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which CF Control is the first listed.
NCT03526107 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03526107 about?
NCT03526107 is a clinical study titled "Food Matrix Effect on Flavanol Absorption, Metabolism and Excretion: Methylxanthines". Dietary intervention study in healthy young adult males to evaluate concentration of flavanol metabolites in plasma and urine after single acute intakes of methylxanthines.
What is the current status of trial NCT03526107?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-02-16. Estimated completion is 2017-05-31.
What conditions does trial NCT03526107 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT03526107?
The interventions under investigation include: CF Control (OTHER), CF-Theobromine (OTHER), CF-Caffeine (OTHER).
Who is sponsoring clinical trial NCT03526107?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03526107 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03526107's enrollment target sits among peer trials
10 1035th of 1090 higher than 35 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI